PRCP is a promising drug target for intracranial aneurysm rupture supported via multi-omics analysis.
Jinghao WuYunyun MeiXinYu LiWen-Kai YuZi Han ZhouYinghao YangPengpeng NiuYun-Chao WangChang-He ShiHanghang ZhuWenjun HeYuan GaoYu-Ming XuYu-Sheng LiPublished in: Stroke and vascular neurology (2024)
This study supports that elevated PRCP gene expression in blood is causally associated with the decreased risk of IA rupture. Conversely, increased PSMA4 expression in the blood is causally related to an increased risk of IA rupture and formation.